Injective

The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.

Approved with 99.89% support, the proposal updates issuance and buyback parameters that govern how INJ is removed from circulation over time.

Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens.

The Cboe has filed to list Canary Capital’s staked Injective ETF, potentially making it the third staked crypto ETF following Solana and Ether.

The move follows SEC guidance treating staking rewards as income, enabling asset managers like Canary to back blockchain-based tokens through delegated staking.

Fund manager Canary Capital has taken a typical first step for an ETF, creating a Delaware trust for a fund that would stake the Injective token.

Deutsche Telekom operates broadband and mobile networks in more than 50 countries through its subsidiaries, such as T-Mobile, and has a customer base of 252 million.

Developers will soon be able to deploy Solana-based AI agent applications on Injective and bridge a variety of cryptocurrencies between them.